Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Jackson Laboratory

Latest From Jackson Laboratory

Boundless Bio Launches With $46m And Novel Oncology Focus On Extrachromosomal DNA

Former Ignyta executive Zachary Hornby wasn't wowed by immuno-oncology pitches when looking for his next cancer drug development company, but was intrigued by ecDNA research at UCSD, which also could generate a tumor agnostic approach.

StartUps and SMEs Financing

Mouse Avatars: Innovative Approach Holds Promise For Personalizing Cancer Treatment

Champions Oncology has developed TumorGraft, a novel predictive chemo-response technology that allows companies to simulate clinical trials, test anticancer drug regimens, and identify the regimens most likely to positively impact individual cancer tumors. For the clinical trial simulation capabilities alone, the technology has a market potential of $1.6 billion in the US, according to the company.

Medical Device Innovation

Charles River Strikes Back In China With Research Models Business

After reassessing its China strategy, Charles River makes a new push by acquiring Vital River, the largest supplier of laboratory animals in China.

China Research & Development

Data, Data Everywhere

As heaps of genetic and chemical data pile up in research databases, Molecular Applications Group is trying to build a business in bioinformatics. But the industry is so new, neither the goals nor the rules are clear. Pricing, service, and standardization are key issues as MAG and its competitors look for business models that not only work today, but can evolve as well.

BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Academic and Research Institutions